Bing Xiao has extensive experience in pricing strategy, health economics, and market access, with a career spanning multiple leading pharmaceutical companies. At HARBOUR BIOMED, Bing held the position of Senior Manager, focusing on health-economics studies and access strategies for novel therapies targeting auto-immune diseases. Subsequently, at Eli Lilly and Company, Bing excelled as Associate Director of Pricing, Reimbursement & Access, leading strategies for diabetes, obesity, and cardio-metabolic health products, and later advanced to Senior Director of National Key Account, overseeing key account management for strategic product access in top hospitals. Prior experience includes a role as Manager of Integrated Access Strategy at Roche, where Bing developed access strategies for various therapeutic areas and led policy advocacy initiatives. Bing's career commenced at GSK as a Management Trainee and Project Manager in Market Access, building foundational skills in sales and project implementation. Academic qualifications include a Master of Science in Biotechnology from the University of Pennsylvania.
This person is not in any teams
This person is not in any offices